The Journal of Intellectual Property (J Intellect Property; JIP)
KCI Indexed
OPEN ACCESS, PEER REVIEWED
pISSN 1975-5945
eISSN 2733-8487
Menu
The Journal of Intellectual Property (hereinafter referred to as JIP) is the official journal of Korea Institute of Intellectual Property (hereinafter referred to as KIIP). It has been published quarterly (on March 30, June 30, September 30, and December 30) since 2006. Anyone who would like to submit a manuscript is advised to carefully read the aims and scope section of this journal. Manuscripts should be prepared for submission to JIP according to the following instructions. JIP adheres to the Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by COPE, DOAJ, WAME, and OASPA; https://doaj.org/apply/transparency/) if not otherwise described below.
JIP welcomes submissions that are directly related to the field of intellectual property, encompassing patents, trademarks, designs, copyrights, and related areas. Submitted papers should demonstrate originality and creativity and contribute meaningfully to disciplines such as law, economics, management, science, and technology.
The editorial team, led by the Editor-in-Chief, reserves the right to reject submissions that do not align with the journal’s focus or meet the required standards of innovation and scholarly rigor.
A submitted manuscript, when published, will become the property of JIP and distributed under the condition of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) available from: https://creativecommons.org/licenses/by-nc-nd/4.0/. Copyrights of all published materials are owned by KIIP.
JIP accepts submissions that have previously been made available as preprints if they have not undergone peer review. A preprint is a draft version of a paper made available online before submission to a journal. Note that posting a preprint does not affect the peer review process.
Manuscripts already published or scheduled to be published in other academic journals, books, public or private research reports, or other publications are excluded from submission. However, manuscripts presented at symposiums or seminars may be submitted, and manuscripts currently under review in other journals may be submitted after a decision of non-acceptance has been made.
The author(s) can make the article available at any post print media, provided the original work is properly cited.
JIP adheres to the ethical guidelines for research and publication described in the Guidelines on Good Publication (https://publicationethics.org/guidance/Guidelines).
Authorship credit should be based on 1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND 2) Drafting the work or revising it critically for important intellectual content; AND 3) Final approval of the version to be published; AND 4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Every author should meet all of these four conditions. After the initial submission of a manuscript, any changes whatsoever in authorship (adding author(s), deleting author(s), or rearranging the order of authors) must be explained by a letter to the editor from the authors concerned. This letter must be signed by all authors of the paper. Copyright assignment must also be completed by every author.
Corresponding author(s) and first author(s): JIP permits multiple corresponding authors and first authors, as long as they are clearly indicated in the manuscript. The authorship notice on the published paper adheres to the style guidelines outlined in the Composition of Manuscripts section. If there are multiple corresponding authors, the submitting author of the manuscript through the online submission system will be responsible for corresponding with the editorial office.
Submitted manuscripts must not have been previously published or be under consideration for publication elsewhere. No part of the accepted manuscript should be duplicated in any other journal without prior permission from the Editorial Board. Upon submission, manuscripts undergo screening for possible plagiarism or duplicate publication using CopyKiller for Korean and iThenticate Similarity Check for English manuscript. If plagiarism or duplicate publication is detected, the manuscript will be rejected, and penalties will be applied to the authors. The process and penalties in such cases adhere to the guidelines outlined in the “Process for managing research and publication misconduct” section.
A letter of permission is required for any and all material that has been published previously. It is the responsibility of the authors to request permission from the publisher for any material that is being reproduced. This requirement applies to text, figures, and tables.
It is possible to republish manuscripts if the manuscripts satisfy the conditions of secondary publication of the ICMJE Recommendations (https://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/overlapping-publications.html).
The corresponding author must inform the editor of any potential conflicts of interest that could influence the authors’ interpretation of the data. Examples of potential conflicts of interest include financial support from or connections to companies, political pressure from interest groups, and academically related issues. In particular, all sources of funding applicable to the study should be explicitly stated.
Research involving humans should be done in accordance with the Ethical Principles for Medical Research Involving Human Subjects, outlined in the Helsinki Declaration of 1975 (revised 2013), available from: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/. Studies involving humans that do not meet the Helsinki Declaration will not be considered for publication. Human subjects should not be identifiable, such that their names, initials, dates of birth, or other protected information should not be disclosed. For animal subjects, research should be performed based on the National or Institutional Guide for the Care and Use of Laboratory Animals, and the ethical treatment of all experimental animals should be maintained.
For studies involving human subjects where identifiable or sensitive information is collected, copies of written informed consent documents must be retained. Identifiable information encompasses personally identifiable information such as names, social security numbers, driver’s license numbers, birthdates, email addresses, and home addresses; health information including diagnoses, treatment records, medical record numbers, biometrics (fingerprints, iris patterns), and DNA sequences; and geographic location data like real-time location and residential addresses. Sensitive information covers health status details such as HIV status, mental health records, reproductive health information; financial data including bank account numbers, credit card numbers, income information; legal information like criminal records and legal dispute histories; racial and ethnic data; sexual orientation and gender identity; political opinions; and religious or philosophical beliefs. For clinical studies involving human subjects, certification, agreement, or approval by the Institutional Review Board (IRB) of the author’s institution is required. If necessary, the editor or reviewers may request copies of these documents to address any queries regarding IRB approval and study conduct.
When JIP encounters suspected cases of research and publication misconduct such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, undisclosed conflicts of interest, ethical issues with a submitted manuscript, instances where a reviewer has appropriated an author’s idea or data, complaints against editors, and so on, the resolution process will follow the flowchart provided by the Committee on Publication Ethics (COPE) (https://publicationethics.org/resources/flowcharts). Discussion and decisions regarding suspected cases are conducted by the Editorial Board.
Cases that require editorial expressions of concern or retraction shall follow the COPE flowcharts available from: https://publicationethics.org/resources/flowcharts. If corrections are needed, they will follow the ICMJE Recommendation for Corrections, Retractions, Republications, and Version Control available from: https://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/corrections-and-version-control.html.
The policy of JIP is primarily aimed at protecting the authors, reviewers, editors, and the publisher of JIP. If not described below, the process of handling complaints and appeals follows the guidelines of the Committee on Publication Ethics available from: https://publicationethics.org/appeals
Who complains or makes an appeal?
Submitters, authors, reviewers, and readers may register complaints and appeals in a variety of cases including falsification, fabrication, plagiarism, duplicate publication, authorship dispute, conflict of interest, ethical treatment of animals, informed consent, bias or unfair/inappropriate competitive acts, copyright, stolen data, defamation, and legal problems. Individuals or institutions wishing to report such cases can send a letter via the contact page on our website: https://www.jip.org/. For complaints or appeals, concrete data along with answers to all factual questions (who, when, where, what, how, why) should be provided.
Who is responsible for resolving and handling complaints and appeals?
The Editor, Editorial Board, or Editorial Office is responsible for them. A legal consultant or ethics editor may assist in decision making.
What may be the consequence of remedy?
It depends on the type or degree of misconduct. The consequence of resolution will follow the COPE guidelines.
The Editorial Board will continuously work to monitor and safeguard publication ethics: guidelines for retracting articles; maintenance of the integrity of the academic record; preclusion of business needs from compromising intellectual and ethical standards; publishing corrections, clarifications, retractions, and apologies when needed; and excluding plagiarism and fraudulent data. The editors maintain the following responsibilities: responsibility and authority to reject and accept articles; avoiding any conflict of interest with respect to articles they reject or accept; promoting publication of corrections or retractions when errors are found; and preserving the anonymity of reviewers.
Korean authors submit manuscripts in Korean. However, if Korean authors wish to publish in English, they must also submit a Korean translation for an accurate review.
Non-Korean authors should primarily submit papers in English (Romanized). If submitting in a language other than English, they must also submit the English title, abstract, and keywords.
Manuscripts are submitted through the online submission system (https://kiip.jams.or.kr/). When submitting manuscripts, authors must provide Copyright Transfer Agreement and Compliance with Publication & Research Ethics, and detailed results of the similarity check for the manuscript.
Author is generally limited to one manuscript per year, but the editorial board may allow up to two manuscripts.
Submissions that do not accurately state the authors’ affiliation and position (author information) or that do not comply with these Instructions will not be accepted.
Manuscripts should be written in the following order: Korean title, table of contents, Korean abstract, Korean keywords, main text, references, English title, English abstract, English keywords.
Manuscripts should be written using the designated template, which is specified in Appendix and the length should not exceed 30 pages.
Manuscripts must use footnotes for citation. Footnotes should be numbered consecutively in the upper right corner of the phrase and detailed at the bottom of the respective page.
Title: Must be indicated in both Korean and English. If there is a subtitle, place a colon ‘:’ between the main title and subtitle. If the paper utilizes results previously presented in other journals or needs additional explanation, cite the source in a footnote marked with an asterisk (*) in superscript next to the title.
Author Name: Must be indicated in both Korean and English, with affiliation and position marked with an asterisk (*) in superscript and noted in the footnotes.
In case of co-authored research: List the first author, followed by others based on their contribution to the paper.
Abstract: Must be provided in both Korean and English. If the paper is written in a language other than English, submit abstracts in both English and the language of the paper.
Table of Contents: The table of contents should list section titles up to the levels of ‘1, 2, …’, ‘1.1, 1.2, …’ etc.
Main Text
Font size for the main text should be 10.5pt, font type Shin Myeongjo, character spacing set to 100%, and line spacing at 160%.
Numbering of section titles in the main text should follow the sequence ‘1, 2, …’, ‘1.1, 1.2, …’, ‘1.1.1, 1.1.2, …’, ‘1.1.1.1, 1.1.1.2, …’, ‘1.1.1.1.1, 1.1.1.1.2,…’ etc.
Tables and figures included in the text should be labeled at the top as <Table 1 ○○>, <Table 2 ○○>,…, <Figure 1 ○○>, <Figure 2 ○○>,… and if they have a source, it should be noted in the footnotes.
References/Footnotes: All documents cited in the text must be fully described, and all documents listed in the references must also be cited in the text.
Keywords: Select more than five keywords for the paper and indicate them in both Korean and English (or other Non-Korean languages).
References and footnotes should be cited in their original language.
References should be listed in the following order: Korean books, Non-Korean books, Korean journals, Non-Korean journals, dissertations, case law, newspaper articles, and online materials, and should be organized alphabetically or in Korean alphabetical order.
When citing the same source multiple times in footnotes, use terms such as “op. cit.”, “supra”, “infra”, “Ibid.”, or equivalent terms in the original language to refer back to previous citations.
When citing the same author multiple times, list references starting from the oldest year; if from the same year, list them in the order cited.
For documents without an author, leave the author’s name blank and denote with an underline.
For works authored by two people, list both names. For works by three or more authors, cite ‘First author et al.’ in Non-Korean languages, and ‘First author and others’ in Korean.
For translations, the author’s name should be given in its original form.
For papers submitted in Non-Korean languages, the format of references and footnotes should follow the citation standards of the author’s country.
The format for references and footnotes is as follows:
1) Korean and East Asian
Author(s), 「Title」, Translator (if applicable), Edition (if more than one), Volume (if multiple), Publisher, Year of Publication, Page numbers.
2) Western
Author(s), Title (italicized), Translator (if applicable), Edition (if more than one), Volume (if multiple), Publisher, Year of Publication, Page numbers (pp.).
1) Korean and East Asian
Author(s), “Article Title”, 「Journal Name」, Volume(Issue)(Year), Page numbers.
2) Western
Author(s), “Article Title”, Journal Name (italicized), Volume(Issue)(Year), Page numbers.
1) Korean and East Asian
Author, “Title”, University, Degree, Year, Page numbers.
2) Western
Author, “Title”, University, Degree, Year, Page numbers.
Cite according to the official publication of the court decisions such as the 「Court Gazette」 or 「Supreme Court Decision Summaries」. Non-Korean case law should follow the standard citation method of that country.
Newspaper articles are cited without specific page numbers, but the author and title can be specified if necessary. For online newspaper articles, follow the example under “(6) Online Materials.”
Author, “Title”, Website, <URL>, date accessed or searched.
Author, “Report Title”, Issuing Body, Year of Publication.
Author, “Material Title”, Issuing Body, Year of Publication.
Despite these guidelines, Non-Korean literature may follow the citation standards applicable in the respective country.
If not specified by these guidelines, the commonly used methods in Korean academic journals can be employed. However, consistency in citation style throughout the paper is required.
There is no publication fee. All costs associated with publication are funded by KIIP.
KIIP supports manuscript fees for papers whose publication has been decided.
Manuscript fees for Korean-language papers:
Manuscript fees for foreign-language papers:
JIP follows a double anonymous peer review, ensuring that both the reviewers and authors remain anonymous to each other. The authors’ names and affiliations are removed during peer review.
(1) Composition of Reviewers
(2) Review Criteria
Reviewers evaluate manuscripts based on the following criteria: